ARCHIVES

NCI Changes Deadlines For Two RFAS

This article is from The Cancer Letter archive.

Vol. 23 No. 28 | July 18, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

NCI-Approved Clinical Trials

March 31, 2006

Poll Finds Voters Support Doubling Of Research Funds.

November 3, 2000

Dexamethasone Improved Survival Of Leukemia

November 26, 2004

After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business

January 19, 1996

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014